Cancer News
Asking the Experts: CAM and Cancer

Complementary and Alternative Treatments in Cancer

Dramatic Responses in B-cell Cancer With Engineered T-cells

Cancer Research UK Working to Improve Info on Wikipedia

Who Needs Zoledronic Acid in Early Breast Cancer?
MD Anderson cost analysis shows proton therapy less costly than IMRT for advanced head/neck cancers

Method to expand blood stem cells could lead to new cancer treatment

Key mechanism in cancer metastasis identified offering potential for therapy

New imaging technique shows how cocaine shuts down blood flow in mouse brains

How repressing the repressors may drive tissue-specific cancers
Faced With Prostate Cancer, It Helps to Know the Enemy

Polyp Removal Doesn't Always Signal Raised Colon Cancer Risk, Study Says

Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says

Number of Young Non-Smokers Who Tried E-Cigs Tripled in 2 Years

Fewer U.S. Teens Using Sunscreen, Study Finds
Vault Nanoparticles Engineered at UCLA Show Promise for Cancer Treatment

JCCC Scientist Honored with Prestigious Biomedical Science Award

PROFILE: Dr. Denis Evseenko—Harnessing the Regenerative Power of Stem Cells in Cancer Research

Four Community Leaders Join Jonsson Cancer Center Foundation Board of Directors

UCLA's Jonsson Comprehensive Cancer Center Once Again Ranks Among Top 10 Cancer Centers Nationwide
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response

Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: Interim analysis

Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non–small-cell lung cancer

Safety and efficacy of thrombopoietin-receptor agonists in myelodysplastic syndromes: A systematic review and meta-analysis of randomized controlled trials

Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer